Preparation of 125I-celecoxib with high purity as a possible tumor agent
Tóm tắt
A preparation of 125I-celecoxib is carried out via an electrophilic substitution reaction. The reaction parameters studied were celecoxib concentration, reaction temperature, pH of the reaction mixture and kinds of oxidizing agents in order to obtain a high radiochemical yield of the 125I-celecoxib. Using 3.7 MBq of Na125I, 150 μg (3.9 mM (mmol/L)) of celecoxib, and 1.6 mM (mmol/L) of chloramine-T (CAT) as oxidant at pH 4 and 60 °C for 15 min a maximum radiochemical yield of 125I-celecoxib (65%) was obtained. The labeled compound was separated and purified by means of high pressure liquid chromatography (HPLC). The biological distribution in infected mice indicates the suitability of radioiodinated celecoxib as imaging of tumor.
Tài liệu tham khảo
Lane NE (1997) J Rheumatol 24(Suppl 49):20
Mandell BF (1999) Clevel Clin J Med 65:285
Silverstein FE, Faich G, Goldstein JL, Simon LS, Pincus T, Whelton A, Makuch R, Eisen G, Agrawal NM, Stenson WF, Burr AM, Zhao WW, Kent JD, Lefkowith JB, Verburg KM, Geis GS (2000) J Am Med Assoc 284:1247
Goldstein JL, Correa P, Zhao WW, Burr AM, Hubbard RC, Verburg KM, Geis GS (2001) Am J Gastroenterol 96:1019
Geis GS (1999) J Rheumatol 26:31
Koki AT, Masferrer JL (2002) Cancer Control 9:28
Grösch S, Maier TJ, Schiffmann S, Geisslinger G (2006) J Natl Cancer Inst 98:736
Hsu AL, Ching TT, Wang DS, Song X, Rangnekar VM, Chen CS (2000) J Biol Chem 275:11397
Kucab JE, Lee C, Chen CS, Zhu J, Gilks CB, Cheang M et al (2005) Breast Cancer Res 7:R796
Patel MI, Subbaramaiah K, Du B, Chang M, Yang P, Newman RA et al (2005) Clin Cancer Res 11:1999
Zhu J, Song X, Lin HP, Young DC, Yan S, Marquez VE et al (2002) J Natl Cancer Inst 94:1745
Kuge Y, Katada Y, Shimonaka S, Temma T, Kimura H, Kiyono Y, Yokota C, Minematsu K, Seki K, Tamaki N, Ohkura K, Saji H (2006) Nucl Med Biol 33:21
Charlton DE, Booz J (1981) Radiat Res 87:10
Unak P (2002) Braz Arch Biol Technol 45:97
Abu-Zeid M, Hori H, Nagasawa H, Uto Y, Inayama S (2000) Biol Pharm Bull 2:195
El-Azony KM, El-Mohty AA, Killa HM, Seddik U, Khater SI (2009) J Label Compd Radiopharm 52:1
El-Azony KM (2004) Arab J Nucl Sci Appl 37:81
Tolmachev V, Bruskin A, Sivaev I, Lundqvist H, Sjöberg S (2002) Radiochem Acta 90:229
Orlova A, Tolmachev V, Lundqvist H (2000) Eur J Nucl Med 27:1210
Petzold G, Coenen HH (1981) J Label Compd Radiopharm 18:139
Knust EJ, Dutschka K, Machulla HJ (1990) J Radioanal Nucl Chem Lett 144:107
Saccavini JC, Bruneau C (1984) IAEA CN 4519:153
Verbruggen RF (1986) Int J Appl Radiat Isot 37:1249